Left Image Right Image

Right Image
Left Image

BinaxNOW™
COVID-19 Antigen Self Test

The test you trust for reliable results in just 15 minutes.

BINAXNOW™ COVID-19 ANTIGEN SELF TEST
BINAXNOW™ COVID-19 ANTIGEN SELF TEST
BINAXNOW™ COVID-19 ANTIGEN SELF TEST


how to use the BinaxNOW COVID-19 Antigen Self Test

reliable COVID-19 results

Please consult the full illustrated instructions included in your kit when taking the test.

Detailed PDF INSTRUCTIONS: ENGLISH | SPANISH
dsfsdf

Open the test card and apply six drops to the top hole only.

dsfsdf

Give both nostrils a shallow swab for about 15 seconds on each side. Big circles – no spinning!

dsfsdf

Stick the swab through the
bottom hole into the top hole. Turn the swab to the right clockwise 3x. Fold the card.

dsfsdf

Wait 15 minutes to see your reliable COVID-19 results.

The Benefits

  • Results in 15 minutes
  • For ages 2+
  • Same technology doctors use to test for COVID-19
  • Detects multiple COVID-19 variants*
  • FSA/HSA eligible

The Benefits

  • Results in 15 minutes
  • For ages 2+
  • Same technology doctors use to test for COVID-19
  • Detects multiple COVID-19 variants*
  • FSA/HSA eligible

Only available in the US.

*The BinaxNOW™ COVID-19 Antigen Self Test has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization. It has been authorized only for the detection of proteins from SARSCoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. 

**1H 2024 Nielson Test Sales Market Data on file

^Some kits may have an additional label added that states “New expiry date. Disregard dates printed on components.”  Original printed expiration date may be covered by this new label.

1. FDA Letter: Revisions Related to Serial (Repeat) Testing for the EUAs of Antigen IVDs. November 1, 2022. Accessed January 26, 2023. https://www.fda.gov/media/162799/download


Please use MakeMyTestCount to report your test results to public health agencies.